Evidence map›Paper›PMID 40833437›Full record

ArticleMolecular diversity2026

Understanding the structural stability and plasticity of VPS34 protein determined by selective/nonselective inhibitors: insights from molecular dynamics simulations.

Liang Yu, Chu Chen, Qianqian Dong, Fangxin Luo, Jiabing Li, Jiqing Ye

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liang Yu *Department of Infectious Disease & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Chu Chen *School of Pharmaceutical Science, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, 230032, China.
Qianqian DongSchool of Pharmaceutical Science, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, 230032, China.
Fangxin LuoDepartment of Infectious Disease & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Jiabing LiDepartment of Infectious Disease & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China. lijiabin@ahmu.edu.cn.
Jiqing YeSchool of Pharmaceutical Science, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, 230032, China. jiqing_ye@ahmu.edu.cn.

Funding

Anhui Province Key Laboratory of Infectious Diseases AHIDL-2402RAnhui Provincial Natural Science Foundation 2308085QH284National Natural Science Foundation of China 82304295University Natural Science Research Project of Anhui Province 2022AH051148
6 · The paper itself

Abstract

Vacuolar sorting protein 34 (VPS34), a sole member of class III phosphoinositide 3-kinase (PI3K), regulates critical cellular processes, such as endosomal trafficking and autophagosome biogenesis, making it a promising target for diseases such as cancer and neurodegenerative disorders. However, developing highly selective inhibitors for VPS34 is challenging due to the structural conservation of its ATP-binding site across PI3Ks. In this study, to elucidate the structural dynamics of selective ligand recognition, we performed molecular dynamics (MD) simulations to explore the conformational landscape of VPS34 in both its apo state and in complex with selective/nonselective ligands. MD simulations and trajectory analysis showed that the whole structural stability and rigidity of VPS34 were increased in the presence of selective ligands. Moreover, pocket dynamical analysis demonstrated that the binding pockets were more stable and conserved upon binding to selective ligands. Furthermore, our results indicated that the ligand selectivity was not determined by the ligand's ability to enter the pocket or residue-level interaction energetics. Overall, these results suggested that the ligand selectivity arose from limiting intrinsic dynamics of VPS34 and thereof increasing its rigidity. These findings offer a new mechanistic framework and structural criteria for the rational design and screening of next-generation selective VPS34 inhibitors.

Indexed as

Class III Phosphatidylinositol 3-KinasesMolecular Dynamics SimulationBinding SitesHumansLigandsProtein BindingProtein ConformationClass III Phosphatidylinositol 3-KinasesLigandsInhibitorMD simulationSelectivityVPS34

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.